Showing results (111-120 of 233) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|April 1, 2021
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory diseaseTony Huynh, Elise Corre, Marie-Paule Lemonnier, et al.
Blood Advances|December 1, 2023
Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experienceNicolas Béranger, Paul Coppo, Vassilis Tsatsaris, et al.
Clinical Case Reports|April 10, 2025
A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case ReportRaffaele Longo, Benjamin Savenkoff, Romane Ribal, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 casesMarie-Agnès Dragon-Durey, Véronique Frémeaux-Bacchi, Chantal Loirat, et al.
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 20, 2019
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpuraOlivier Garraud, Sandrine Malot, Raoul Herbrecht, et al.
British Journal of Haematology|July 19, 2006
BCR-ABL activates STAT3 via JAK and MEK pathways in human cellsPaul Coppo, Stéphane Flamant, Véronique De Mas, et al.
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
Pageof 24